Förderungen
Alle Förderungen
21,572 Ergebnisse · Seite 105 von 1079
- Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)05 Nov 2027noch 394 Tage
- Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)05 Nov 2027noch 394 Tage
- Appel à projets 'Parcours Transition écologique des brasseries artisanales'06 Nov 2027noch 395 Tage
- BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed)08 Nov 2027noch 397 Tage
- NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed)12 Nov 2027noch 401 Tage
- Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed)12 Nov 2027noch 401 Tage
- Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required)12 Nov 2027noch 401 Tage
- Subvention Prévention TPE - Caisse sécurisée15 Nov 2027noch 404 Tage
- Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional)15 Nov 2027noch 404 Tage
- Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed)15 Nov 2027noch 404 Tage
- Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed)16 Nov 2027noch 405 Tage
- Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)16 Nov 2027noch 405 Tage
- Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)16 Nov 2027noch 405 Tage
- Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)16 Nov 2027noch 405 TageUS$200,000
- Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)16 Nov 2027noch 405 Tage
- Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)18 Nov 2027noch 407 TageUS$300,000
- Horizon Europe: Ausweitung der Beteiligung und Verbreitung von Exzellenz (WIDERA-Widening)18 Nov 2027noch 408 Tage
- DEVCOM ARMY RESEARCH LABORATORY BROAD AGENCY ANNOUNCEMENT FOR FOUNDATIONAL RESEARCH20 Nov 2027noch 409 Tage
- Realizace nástrojů politiky zaměstnanosti na národní úrovni26 Nov 2027noch 416 Tage
- Avviso "Quota Lombardia" a sostegno delle PMI lombarde30 Nov 2027noch 419 Tage€25,000,000